CDC News: Enhancing testing, treatment, and PrEP uptake is key to ending the U.S. HIV epidemic

As many as 185,000 new HIV infections could be prevented by reaching the National HIV/AIDS strategy (NHAS) targets for HIV testing and treatment and expanding the use of pre-exposure prophylaxis (PrEP) in the U.S., according to a new CDC report released today.

This study released at the 2016 Conference on Retroviruses and Opportunistic Infections in Boston show:

• Reaching national targets for HIV testing and treatment and scaling up use of PrEP could reduce new HIV infections in the United States by as much as 70 percent (185,000 infections)– infections by 2020.
• Achieving NHAS testing and treatment goals (90% diagnoses rate and 80% viral suppression rate among people living with HIV) could prevent 168,000 new HIV infections by 2020
• Rapid uptake of daily oral PrEP would prevent another 17,000 new HIV infections by 2020 (if 40% high-risk MSM, 10% IDU, 10% HRH used PrEP)
• Several alternate levels of success were also examined by researchers, illustrated with our graph of the expanded HIV treatment and testing scenarios.

For more information, see our press releases. Please see our online newsroom for more information on the research presented at this year’s conference.